Mustang Bio, Inc.
General ticker "MBIO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $35.9M (TTM average)
Mustang Bio, Inc. does not follow the US Stock Market performance with the rate: -8.1%.
Estimated limits based on current volatility of 5.8%: low 1.20$, high 1.34$
Factors to consider:
- Total employees count: 80 (-29.2%) as of 2023
- Top business risk factors: Operational and conduct risks, Dependence on product candidates, Regulatory and compliance, Geopolitical risks, Labor/talent shortage/retention
- Current price 67.2% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.02$, 15.04$]
- 2025-12-31 to 2026-12-31 estimated range: [2.15$, 8.63$]
Financial Metrics affecting the MBIO estimates:
- Negative: with PPE of -0.1 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -21.55 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Negative: Shareholder equity ratio, % of -41.61 <= 18.93
- Negative: Industry earnings per price (median), % of -16.34 <= 0
Short-term MBIO quotes
Long-term MBIO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $76.16MM | $50.73MM | $16.25MM |
| Operating Income | $-76.16MM | $-50.73MM | $-16.25MM |
| Non-Operating Income | $-1.37MM | $-0.88MM | $0.49MM |
| Interest Expense | $3.36MM | $1.31MM | $0.01MM |
| R&D Expense | $63.95MM | $39.18MM | $8.42MM |
| Income(Loss) | $-77.53MM | $-51.60MM | $-15.75MM |
| Profit(Loss)* | $-77.53MM | $-51.60MM | $-15.75MM |
| Stockholders Equity | $46.27MM | $0.12MM | $-3.87MM |
| Assets | $92.42MM | $17.74MM | $9.31MM |
| Operating Cash Flow | $-65.07MM | $-49.48MM | $-11.41MM |
| Capital expenditure | $3.08MM | $0.11MM | $0.00MM |
| Investing Cash Flow | $-2.95MM | $5.89MM | $0.00MM |
| Financing Cash Flow | $34.06MM | $-26.08MM | $11.27MM |
| Earnings Per Share** | $-11.24 | $-6.00 | $-2.57 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.